Article Details

Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran ...

Retrieved on: 2024-04-08 11:27:56

Tags for this article:

Click the tags to see associated articles and topics

Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran .... View article details on hiswai:

Excerpt

Basel - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam today released detailed results from the Phase II KARDIA-2 study evaluating the efficacy ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up